emily petricola and paul murnane

Australia Day honours for MS and disability Advocates

MS advocates Emily Petricola OAM and Paul Murnane AM have been recognised in The Australia Day Honours List for 2022.
EBV and MS

New evidence: Does the Epstein-Barr virus cause MS?

A new study has provided the strongest evidence yet that infection with the Epstein-Barr virus (EBV), which causes glandular fever, may also cause MS.
2021 Priorities Survey

2021 Priorities Survey: The results are in!

The results are now in from our 2021 Priorities Survey. With your help, we have understood which of the many different areas of MS research and advocacy are considered the most important by people directly and indirectly affected by MS.
letter from Des

Strengthening our resolve for research and advocacy: A letter from our President

MS Australia President Associate Professor Des Graham presents 'A world without MS: Strategic Plan 2022-2026'.
rohan greenland

50 years of progress: A note from our CEO, Rohan Greenland

CEO Rohan Greenland gives an update on the MS Australia activities for the year ahead, focusing on the newly launched five-year strategic plan.
amy and family

Amy started 2022 full of hope, thanks to you!

How your support is helping solve the biggest challenges of MS – and giving people like Amy their life back.

COVID-19 vaccination and boosters: What does this all mean?

The COVID-19 pandemic is ever-evolving; however, we are constantly monitoring developments and providing the latest information on our website. Here we unpack the difference between a primary course of vaccination and boosters.
ms onset children

Could time outdoors reduce MS development in children?

Researchers have explored the contributions of sun exposure and ultraviolet radiation (UVR) to the risk of children developing MS.
soliris NMOSD

NMOSD medication not recommended for the PBS for a second time

Soliris® (eculizumab), the first TGA-approved medication for NMOSD, has not been recommended for listing on the PBS.

ATA188: Improvements in progressive MS maintained in extension of initial trials

New imaging data shows sustained improvement in disability and increases in myelin density in the brain following an experimental treatment for progressive MS.
rohan greenland

A note from our CEO: Rohan Greenland – December

CEO Rohan Greenland gives an update on the MS Australia activities for December, focusing on the year ahead for MS Australia.
The May 50K 2021

Thank you for raising over $5.3 million for MS research in 2021

We look back on the enormous milestones reached in 2021 thanks to the Kiss Goodbye to MS community. Thank you for continuing to accelerate our superpower – MS research.
NDIS support

Does NDIS support match the level of disability needs for people with MS?

A recent study from regional NSW is the first to assess if the NDIS package allocated to people with MS matches the level of disability measured by a formal neurological assessment. 
myelin cell neuron

What drives myelin damage in MS?

A new study of brain tissue has found that immune cells derived from blood immune cells, attack myelin in the very early stages of MS.

Reflecting on International Day of People with Disability 2021

MS Australia National Advocate Erin Brady reflects on International Day of People with Disability in a post-pandemic world.
Kiss Goodbye to MS Ambassadors

The inspiring Australians who are making a difference

Our Kiss Goodbye to MS ambassadors say thank you to the fantastic MS community by sharing their very own thank you letters.
remyelination MS

Is a naturally occurring molecule the key to remyelination?

MS researchers have investigated whether a naturally occurring molecule, which some DMTs mimic, has the capacity to promote myelin repair.
2021 prime awards

MS Australia shortlisted for 2021 Prime Awards

CEO Rohan Greenland gives an update on the MS Australia activities for November, focusing on MS Australia's 2021 Prime Award nomination.

Newsletter subscription

  • Enter your details

Australia Day honours for MS and disability Advocates